The Diagnosis and Treatment of Fungal Endophthalmitis: An Update

In recent, large case series of fungal endophthalmitis (FE) that were published by Asian authors, the most frequent etiologic agents for all types of FE are molds (usually Aspergillus species, while Fusarium is the prevalent etiology in keratitis-related FE). Candida was the organism found in most cases of endogenous FE. However, we must keep in mind that prevalence of fungal species varies with the geographical area. Lately, polymerase chain reaction (PCR) was increasingly used for the diagnosis of FE, allowing for very high diagnostic sensitivity, while the costs become more affordable with time. The most important shortcoming of PCR—the limited number of pathogens that can be simultaneously searched for—may be overcome by newer techniques, such as next-generation sequencing. There are even hopes of searching for genetic sequences that codify resistance to antifungals. We must not forget the potential of simpler tests (such as galactomannan and β-d-glucan) in orienting towards a diagnosis of FE. There are few reports about the use of newer antifungals in FE. Echinocandins have low penetration in the vitreous cavity, and may be of use in cases of fungal chorioretinitis (without vitritis), or injected intravitreally as an off-label, salvage therapy.

[1]  M. Soleimani,et al.  Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi-experimental study , 2022, BMC Ophthalmology.

[2]  A. Pathengay,et al.  Sight-threatening intraocular infection in patients with COVID-19 in India , 2021, Indian journal of ophthalmology.

[3]  Chinmay P. Nakhwa Endogenous fungal endopthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: A case report , 2021, Indian journal of ophthalmology.

[4]  Abdelrahman M. Elhusseiny,et al.  Fungal Endophthalmitis: A Comprehensive Review , 2021, Journal of fungi.

[5]  Kaili Wu,et al.  Comparison of causative microorganisms of posttraumatic endophthalmitis with and without retained intraocular foreign bodies , 2021, BMC Ophthalmology.

[6]  S. Chee,et al.  Candida Endophthalmitis Treated Successfully With Isavuconazole: A Case Report , 2021, Open forum infectious diseases.

[7]  T. Das,et al.  Fungal endophthalmitis: Analysis of 730 consecutive eyes from seven tertiary eye care centers in India. , 2021, Ophthalmology. Retina.

[8]  Aisi Fu,et al.  Microbiological diagnosis of endophthalmitis using nanopore targeted sequencing , 2021, Clinical & experimental ophthalmology.

[9]  J. B. Bond,et al.  American Academy of Ophthalmology recommendations on screening for endogenous Candida endophthalmitis. , 2021, Ophthalmology.

[10]  P. White,et al.  Molecular Diagnosis of Yeast Infections , 2021, Current Fungal Infection Reports.

[11]  Daraius Shroff,et al.  Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease , 2021, Indian journal of ophthalmology.

[12]  P. Majumder,et al.  A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients , 2021, Indian journal of ophthalmology.

[13]  Kazuaki Matsumoto,et al.  Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis , 2021, Journal of fungi.

[14]  T. Lupia,et al.  Exogenous Fungal Endophthalmitis: Clues to Aspergillus Aetiology with a Pharmacological Perspective , 2020, Microorganisms.

[15]  L. Ostrosky-Zeichner,et al.  Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance , 2020, Journal of fungi.

[16]  Tapan P. Patel,et al.  Antimicrobial guide to posterior segment infections , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[17]  T. Mir,et al.  Incidence of Drug Use-Related Endogenous Endophthalmitis Hospitalizations in the United States, 2003 to 2016. , 2020, JAMA ophthalmology.

[18]  Ting Zhang,et al.  Vitrectomy combined with intravitreal antifungal therapy for posttraumatic fungal endophthalmitis in eastern China , 2020, BMC Ophthalmology.

[19]  S. Ormanns,et al.  Comparison of β-D-Glucan and Galactomannan in Serum for Detection of Invasive Aspergillosis: Retrospective Analysis with Focus on Early Diagnosis , 2020, Journal of fungi.

[20]  Nicoleta Anton,et al.  Endogenous Endophthalmitis: A Review of Case Series Published between 2011 and 2020 , 2020, Journal of ophthalmology.

[21]  Ruben Lim Bon Siong,et al.  Infectious endophthalmitis at a Philippine tertiary hospital: a ten-year retrospective study , 2020, Journal of Ophthalmic Inflammation and Infection.

[22]  H. Flynn,et al.  The Role of Systemic Antimicrobials in the Treatment of Endophthalmitis: A Review and an International Perspective , 2020, Ophthalmology and Therapy.

[23]  O. Kurzai,et al.  Case Report: Beyond the Blood-retina Barrier: Intravitreal Caspofungin for Fungal Endophthalmitis. , 2020, Optometry and vision science : official publication of the American Academy of Optometry.

[24]  F. Kuhn,et al.  Complete and Early Vitrectomy for Endophthalmitis After Cataract Surgery: An Alternative Treatment Paradigm , 2020, Clinical ophthalmology.

[25]  G. Ying,et al.  CLINICAL UTILITY OF BETA-D-GLUCAN TESTING FOR ENDOGENOUS FUNGAL CHORIORETINITIS OR ENDOPHTHALMITIS. , 2020, Retina.

[26]  T. Mir,et al.  Trends in Infantile Endogenous Endophthalmitis Hospitalizations in the United States: An Analysis from 2007-2014 using the National Inpatient Sample. , 2020, Ophthalmology. Retina.

[27]  F. Persat,et al.  Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing? , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[28]  Gopal S. Pillai,et al.  Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in South India , 2020, Indian journal of ophthalmology.

[29]  A. Pathengay,et al.  Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India , 2020, Indian journal of ophthalmology.

[30]  K. Ramasamy,et al.  Post-cataract Surgery Fungal Endophthalmitis: Management Outcomes and Prognostic Factors , 2020, Ocular immunology and inflammation.

[31]  Xiaofeng Hu,et al.  Utility of Intraocular Fluid β-D-glucan Testing in Fungal Endophthalmitis: A Series of 5 Cases , 2020, The American journal of case reports.

[32]  Nila S. Radhakrishnan,et al.  Endogenous Endophthalmitis: yield of the diagnostic evaluation , 2020, BMC Ophthalmology.

[33]  A. Pathengay,et al.  Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes. , 2020, Asia-Pacific journal of ophthalmology.

[34]  B. Seitz,et al.  Recurrent fungal endophthalmitis after intravitreal injections of bevacizumab , 2020, American journal of ophthalmology case reports.

[35]  Mengjie Liu,et al.  Endophthalmitis associated with fungal keratitis and penetrating injuries in North China , 2020, European journal of ophthalmology.

[36]  L. Spadea,et al.  Diagnostic and Management Strategies of Aspergillus Endophthalmitis: Current Insights , 2019, Clinical ophthalmology.

[37]  Savitri Sharma,et al.  Targeted High-Throughput Sequencing Identifies Predominantly Fungal Pathogens in Patients with Clinically Infectious, Culture-Negative Endophthalmitis in South India , 2019, Microorganisms.

[38]  P. Singh,et al.  Pathobiology of Aspergillus Fumigatus Endophthalmitis in Immunocompetent and Immunocompromised Mice , 2019, Microorganisms.

[39]  L. Gopal,et al.  Endogenous endophthalmitis in children and adolescents: Case series and literature review , 2019, Indian journal of ophthalmology.

[40]  Jun Cheng,et al.  RISK FACTORS, TREATMENT STRATEGIES, AND OUTCOMES OF ENDOPHTHALMITIS ASSOCIATED WITH SEVERE FUNGAL KERATITIS. , 2019, Retina.

[41]  H. Ikeuchi,et al.  The incidence of endophthalmitis or macular involvement and the necessity of a routine ophthalmic examination in patients with candidemia , 2019, PloS one.

[42]  A. Pathengay,et al.  Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile , 2019, Journal of Ophthalmic Inflammation and Infection.

[43]  T. Walsh,et al.  Fungal Endophthalmitis after Intravitreal Injections of Triamcinolone Contaminated by a Compounding Pharmacy: Five-Year Follow-up of 23 Patients. , 2019, Ophthalmology. Retina.

[44]  Savitri Sharma,et al.  New insights into culture negative endophthalmitis by unbiased next generation sequencing , 2019, Scientific Reports.

[45]  H. Kaplan,et al.  Diagnostic Utility of Quantitative Polymerase Chain Reaction versus Culture in Endophthalmitis and Uveitis , 2019, Ocular immunology and inflammation.

[46]  P. Singh,et al.  Isavuconazole for Treatment of Experimental Fungal Endophthalmitis Caused by Aspergillus fumigatus , 2018, Antimicrobial Agents and Chemotherapy.

[47]  A. Grzybowski,et al.  The treatment of postoperative endophthalmitis: should we still follow the endophthalmitis vitrectomy study more than two decades after its publication? , 2018, Acta ophthalmologica.

[48]  Andrea D. Tyler,et al.  Evaluation of Oxford Nanopore’s MinION Sequencing Device for Microbial Whole Genome Sequencing Applications , 2018, Scientific Reports.

[49]  F. Otero-Espinar,et al.  Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis , 2018, Pharmaceutics.

[50]  Cecilia S Lee,et al.  A Review of the Role of Intravitreal Corticosteroids as an Adjuvant to Antibiotics in Infectious Endophthalmitis , 2018, Ocular immunology and inflammation.

[51]  L. López-Soria,et al.  Endophthalmitis caused by Fusarium: An emerging problem in patients with corneal trauma. A case series. , 2018, Revista iberoamericana de micologia.

[52]  N. Davies,et al.  A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis , 2018, Eye.

[53]  M. Cavo,et al.  Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia , 2018, Mycoses.

[54]  Sukhum Silpa-archa,et al.  Culture-Positive Endogenous Endophthalmitis: An Eleven-Year Retrospective Study in the Central Region of Thailand , 2017, Ocular immunology and inflammation.

[55]  T. Das,et al.  ROLE OF EARLY VITRECTOMY IN THE TREATMENT OF FUNGAL ENDOPHTHALMITIS , 2017, Retina.

[56]  Joan W. Miller,et al.  Endogenous Endophthalmitis in the American and Korean Population: An 8-year Retrospective Study , 2015, Ocular immunology and inflammation.

[57]  K. Maruyama,et al.  Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications , 2018, Mycopathologia.

[58]  J. Buer,et al.  Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[59]  D. Marriott,et al.  Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance. , 2017, Journal of visualized experiments : JoVE.

[60]  A. M. Garrido-Hermosilla,et al.  Extreme Surgical Maneuvers in Fungal Endophthalmitis , 2017, Ophthalmologica.

[61]  J. Losa,et al.  Is routine ophthalmoscopy really necessary in candidemic patients? , 2017, PloS one.

[62]  P. White,et al.  Diagnostic accuracy of fungal PCR and β-d-glucan for detection of candidaemia: a preliminary evaluation , 2017, Journal of Clinical Pathology.

[63]  Ya-Chung Tian,et al.  Epidemiology and outcomes of Endophthalmitis in chronic dialysis patients: a 13-year experience in a tertiary referral center in Taiwan , 2017, BMC Nephrology.

[64]  Nicoleta Anton,et al.  The Importance of Fluconazole in Treatment of Endogenous Endophtalmitis in Patients Prior Treated Using Negative Pressure Therapy for Wound Closure Contaminated with Meticillin-resistant Staphylococcus aureus , 2017 .

[65]  D. Perlin,et al.  Culture-Independent Molecular Methods for Detection of Antifungal Resistance Mechanisms and Fungal Identification , 2017, The Journal of infectious diseases.

[66]  Xiaofeng Lin,et al.  Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China , 2017, Journal of ophthalmology.

[67]  M. la Cour,et al.  59 eyes with endogenous endophthalmitis– causes, outcomes and mortality in a Danish population between 2000 and 2016 , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[68]  M. Castanheira,et al.  Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans , 2017, Antimicrobial Agents and Chemotherapy.

[69]  J. Duker,et al.  An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England , 2017, JAMA ophthalmology.

[70]  Boben Thomas,et al.  Management of a case of Candida albicans endogenous endophthalmitis with intravitreal caspofungin , 2017, Indian Journal of Ophthalmology.

[71]  D. Chiselita,et al.  Successful treatment of fungal endophthalmitis using intravitreal caspofungin. , 2017, Arquivos Brasileiros de Oftalmologia.

[72]  Avni P. Finn,et al.  Intravenous Drug Use-Associated Endophthalmitis. , 2017, Ophthalmology. Retina.

[73]  H. Flynn,et al.  Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis , 2017, Retina.

[74]  N. Nayak,et al.  Clinicomicrobiological profile of endophthalmitis: A 10 year experience in a Tertiary Care Center in North India , 2017, Indian journal of pathology & microbiology.

[75]  K. Bartz-Schmidt,et al.  Outcomes of Primary Transconjunctival 23-Gauge Vitrectomy in the Diagnosis and Treatment of Presumed Endogenous Fungal Endophthalmitis , 2017, Ocular immunology and inflammation.

[76]  D. Denning,et al.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[77]  N. Curtis,et al.  Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre. , 2016, The Journal of antimicrobial chemotherapy.

[78]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  H. Flynn,et al.  Endophthalmitis: state of the art , 2015, Clinical ophthalmology.

[80]  Bingqian Liu,et al.  Causative organisms of post-traumatic endophthalmitis: a 20-year retrospective study , 2014, BMC Ophthalmology.

[81]  A. Chakrabarti,et al.  Management of recurrent postoperative fungal endophthalmitis , 2014, Indian journal of ophthalmology.

[82]  Ajay E. Kuriyan,et al.  Endogenous fungal endophthalmitis: risk factors, clinical features, and treatment outcomes in mold and yeast infections , 2013, Journal of Ophthalmic Inflammation and Infection.

[83]  H. Flynn,et al.  Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. , 2013, American journal of ophthalmology.

[84]  A. Friedman,et al.  An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone. , 2013, JAMA ophthalmology.

[85]  P. McCluskey,et al.  FACTORS DETERMINING VISUAL OUTCOME IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS , 2012, Retina.

[86]  P. Sowmya,et al.  Diagnostic Utility of Polymerase Chain Reaction on Intraocular Specimens to Establish the Etiology of Infectious Endophthalmitis , 2009, European journal of ophthalmology.

[87]  B. Tarai,et al.  FUNGAL ENDOPHTHALMITIS: Fourteen Years’ Experience From a Center in India , 2008, Retina.

[88]  N. Rao,et al.  A comparative clinicopathologic study of endogenous mycotic endophthalmitis: variations in clinical and histopathologic changes in candidiasis compared to aspergillosis. , 2000, Transactions of the American Ophthalmological Society.

[89]  T. Das,et al.  Role of intravitreal dexamethasone in exogenous fungal endophthalmitis , 1999, Eye.

[90]  C E Letocha,et al.  The American Academy of Ophthalmology. , 1996, Archives of ophthalmology.

[91]  L. Ficker,et al.  Infectious endophthalmitis. , 1986, Transactions of the ophthalmological societies of the United Kingdom.